loading
Schlusskurs vom Vortag:
$1.20
Offen:
$1.25
24-Stunden-Volumen:
507.13K
Relative Volume:
0.89
Marktkapitalisierung:
$39.31M
Einnahmen:
$1.05M
Nettoeinkommen (Verlust:
$-48.82M
KGV:
-0.735
EPS:
-1.83
Netto-Cashflow:
$-47.49M
1W Leistung:
+6.35%
1M Leistung:
-13.55%
6M Leistung:
-28.72%
1J Leistung:
-81.31%
1-Tages-Spanne:
Value
$1.23
$1.39
1-Wochen-Bereich:
Value
$1.165
$1.39
52-Wochen-Spanne:
Value
$1.06
$10.24

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Firmenname
Actinium Pharmaceuticals Inc
Name
Telefon
646-767-3870
Name
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Name
Mitarbeiter
25
Name
Twitter
@actiniumpharma
Name
Nächster Verdiensttermin
2025-03-14
Name
Neueste SEC-Einreichungen
Name
ATNM's Discussions on Twitter

Vergleichen Sie ATNM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.345 39.31M 1.05M -48.82M -47.49M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.63 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.35 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.91 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.34 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
252.91 26.16B 3.81B -644.79M -669.77M -6.24

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-07 Herabstufung B. Riley Securities Buy → Neutral
2024-05-14 Eingeleitet Stephens Overweight
2023-09-06 Eingeleitet HSBC Securities Buy
2023-02-21 Herabstufung William Blair Outperform → Mkt Perform
2022-09-08 Eingeleitet Cantor Fitzgerald Overweight
2022-08-25 Eingeleitet B. Riley Securities Buy
2020-11-05 Eingeleitet Alliance Global Partners Buy
2017-12-06 Eingeleitet B. Riley FBR, Inc. Buy
2017-10-23 Fortgesetzt ROTH Capital Buy
2017-09-14 Eingeleitet Maxim Group Buy
2016-08-25 Eingeleitet ROTH Capital Buy
2016-02-29 Eingeleitet H.C. Wainwright Buy
2015-10-15 Eingeleitet FBR Capital Outperform
2014-10-01 Eingeleitet MLV & Co Buy
2014-07-22 Eingeleitet Canaccord Genuity Buy
Alle ansehen

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

pulisher
02:58 AM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - PR Newswire

02:58 AM
pulisher
10:24 AM

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

10:24 AM
pulisher
05:46 AM

Levi & Korsinsky Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 27, 2025ATNM - marketscreener.com

05:46 AM
pulisher
Apr 21, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Solaris, Actinium, Bakkt, and Cerevel and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Apr 21, 2025
pulisher
Apr 21, 2025

Actinium Pharmaceuticals, Inc. Class Action: Levi & - GlobeNewswire

Apr 21, 2025
pulisher
Apr 21, 2025

Actinium Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Actinium Investors of - Bluefield Daily Telegraph

Apr 21, 2025
pulisher
Apr 21, 2025

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire

Apr 21, 2025
pulisher
Apr 20, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 20, 2025
pulisher
Apr 20, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire

Apr 20, 2025
pulisher
Apr 18, 2025

ATNM INVESTORS: Kirby McInerney LLP Reminds Actinium Pharmaceuticals, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm - TradingView

Apr 18, 2025
pulisher
Apr 18, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 18, 2025
pulisher
Apr 18, 2025

Actinium Pharmaceuticals, Inc. Sued for Securities Law - GlobeNewswire

Apr 18, 2025
pulisher
Apr 18, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. LawsuitATNM - MarketScreener

Apr 18, 2025
pulisher
Apr 18, 2025

Actinium Pharmaceuticals (NYSE:ATNM) Stock Rating Upgraded by StockNews.com - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

The Gross Law Firm Reminds Actinium Pharmaceuticals, Inc. - GlobeNewswire

Apr 17, 2025
pulisher
Apr 17, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 17, 2025
pulisher
Apr 17, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium Pharmaceuticals, Inc. LawsuitATNM - PR Newswire

Apr 17, 2025
pulisher
Apr 16, 2025

ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Actinium Pharmaceuticals, Inc. Investors: Please contact - GlobeNewswire

Apr 16, 2025
pulisher
Apr 15, 2025

Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - The Malaysian Reserve

Apr 15, 2025
pulisher
Apr 15, 2025

ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 15, 2025
pulisher
Apr 15, 2025

ROSEN, A LEADING NATIONAL FIRM, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Actinium Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 27, 2025 Deadline to file Lead Plaintiff Motion - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit - Bluefield Daily Telegraph

Apr 15, 2025
pulisher
Apr 14, 2025

ATNM Investors are Reminded of the Class Action Against Actinium Pharmaceuticals, Inc.: Contact Robbins LLP for Information About How to Become Lead Plaintiff for the Class - PR Newswire

Apr 14, 2025
pulisher
Apr 13, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 13, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Invests $62,000 in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure - Bluefield Daily Telegraph

Apr 12, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium - GlobeNewswire

Apr 12, 2025
pulisher
Apr 12, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 12, 2025
pulisher
Apr 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in - Bluefield Daily Telegraph

Apr 12, 2025
pulisher
Apr 11, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Actinium LawsuitATNM - PR Newswire

Apr 11, 2025
pulisher
Apr 10, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 10, 2025
pulisher
Apr 10, 2025

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATNM - Morningstar

Apr 10, 2025
pulisher
Apr 09, 2025

Lawsuit filed for Investors who lost money with shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - TradingView

Apr 09, 2025
pulisher
Apr 09, 2025

ATNM LAWSUIT ALERT: Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

Levi & Korsinsky Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATNM - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

The Gross Law Firm Notifies Shareholders of Actinium Pharmaceuticals, Inc.(ATNM) of a Class - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 09, 2025
pulisher
Apr 08, 2025

ATNM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Actinium Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com

Apr 08, 2025
pulisher
Apr 08, 2025

Actinium Pharmaceuticals, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - PR Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Receives $7.40 Consensus Target Price from Analysts - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Shareholders of Actinium Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before May 27, 2025 to Discuss Your RightsATNM - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

ATNM Stockholders Should Contact Robbins LLP for Information on How to Lead the Class Action Against Actinium Pharmaceuticals, Inc. - PR Newswire

Apr 07, 2025

Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Kapitalisierung:     |  Volumen (24h):